Ignite Creation Date:
2025-12-25 @ 4:26 AM
Ignite Modification Date:
2025-12-26 @ 3:30 AM
Study NCT ID:
NCT01062620
Status:
COMPLETED
Last Update Posted:
2011-09-15
First Post:
2010-02-03
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Dose Escalating Clinical Trial of the IGF-1 Receptor Inhibitor AXL1717 in Patients With Advanced Cancer
Sponsor:
Axelar AB
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-04
Start Date Type:
None
Primary Completion Date:
2011-05
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2010-02-03
First Submit QC Date:
None
Study First Post Date:
2010-02-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-09-14
Last Update Post Date:
2011-09-15
Last Update Post Date Type:
ESTIMATED